Sigma Advanced Systems divests 36.52% of Swiss pharma stake to enhance focus and investment in aerospace and defence sector.
Sigma Advanced divests stake in Swiss pharma firm to sharpen focus on aerospace and defence business
Sigma Advanced Systems divests 36.52% of Swiss pharma stake to enhance focus and investment in aerospace and defence sector.